Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
agj18pXpSsr8Bbqe
Listen
